Articles related to COGNITIVE HEALTH/MEMORY

Amantadine emerges as the pharmacologic agent with the most support for improving cognitive impairment after TBI, while cognitive rehabilitation interventions demonstrate substantial evidence for enhancing neurocognitive function and reducing functional limitations.

A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.

LANS presents with memory symptoms that mimic Alzheimer’s disease, but brain imaging and biomarkers indicate a different underlying condition, potentially leading to more accurate diagnoses and prognoses for older adults with cognitive decline.

Lion’s mane mushroom stimulates nerve growth factor production, potentially supporting neuron growth and survival, with implications for cognitive health and neurological disorders.

Early ovary removal may lead to abrupt endocrine dysfunction, potentially increasing the risk of cognitive impairment and dementia in women.

Kisunla’s approval introduces a novel treatment option for early Alzheimer’s disease, potentially altering the landscape of AD management with its ability to significantly reduce amyloid plaque levels and slow cognitive decline.